Loading clinical trials...
Loading clinical trials...
Memantine has shown promise in mitigating secondary brain injury in previous studies. One study demonstrated that early memantine administration in moderate TBI patients resulted in lower serum neuron...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mansoura University
NCT05762796 · Brain Concussion, Mild Traumatic Brain Injury, and more
NCT07356167 · Mild Traumatic Brain Injury
NCT07311486 · Mild Traumatic Brain Injury (mTBI)
NCT06628505 · Mild Traumatic Brain Injury
NCT07097792 · Brain Concussion, Mild Traumatic Brain Injury, and more
Mansoura University
Al Mansurah, Dakahlia Governorate
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions